Clinical Trial Update: Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports results for triple-therapy in patients with Hepatitis C genotype 3 who previously failed treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Calgary | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2015-09-21